as on October 29, 2025 at 1:29 am IST
Day's Low
Day's High
2.82%
Downside
1.88%
Upside
52 Week's Low
52 Week's High
45.14%
Downside
55.64%
Upside
Check Grace Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$43.5M
EPS (TTM)
-1.588
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-16.78%
Compare market cap, revenue, PE, and other key metrics of Grace Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $43.5M | NA | NA | 0.00% | |
| BUY | $60.7B | 283.23% | -505.15 | -12.96% | |
| NA | $35.8B | NA | NA | -3.89% | |
| BUY | $108.0B | 101.68% | 29.95 | 31.86% | |
| BUY | $61.3B | 3.22% | 14.55 | 31.37% |
The Grace Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Grace Therapeutics Inc investment value today
Current value as on today
₹1,04,509
Returns
₹4,509
(+4.51%)
Returns from Grace Therapeutics Inc Stock
Dollar Returns*
₹5,132 (+5.13%)
Search interest for Grace Therapeutics Inc Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:33% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, GRCE stock has moved up by 1.9%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 134.0% return, outperforming this stock by 141.0%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.8% return, outperforming this stock by 68.7%
| Organisation | Grace Therapeutics Inc |
| Headquarters | 103 Carnegie Center, Princeton, NJ, United States, 08540 |
| CEO | Mr. Prashant Kohli |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Prashant Kohli | CEO & Director |
Mr. Amresh Kumar Ph.D. | VP of Program Management |
Ms. Carrie D'Andrea | VP of Clinical Operations |
Mr. Robert J. DelAversano CPA | VP of Finance and Principal Financial & Accounting Officer |
Dr. R. Loch MacDonald M.D., Ph.D. | Member of Scientific Advisory Board & Chief Medical Officer |
Grace Therapeutics Inc share price today is $3.19 as on at the close of the market. Grace Therapeutics Inc share today touched a day high of $3.25 and a low of $3.1.
Grace Therapeutics Inc share touched a 52 week high of $4.97 on and a 52 week low of $1.75 on . Grace Therapeutics Inc stock price today i.e. is closed at $3.19,which is 35.75% down from its 52 week high and 82.29% up from its 52 week low.
Grace Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Grace Therapeutics Inc (GRCE) shares with as little as ₹88.237 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.37 in Grace Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Grace Therapeutics Inc share’s latest price of $3.19 as on October 29, 2025 at 1:29 am IST, you will get 3.1348 shares of Grace Therapeutics Inc. Learn more about
fractional shares .